Introduction

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Beginning with the first reports in 2001 and continuing to the present time, exposed bone in the jaws and, more recently, femoral fractures caused by the toxic effects of bisphosphonates on osteoclasts have become epidemic. In less than 10 years, more than 1,100 publications have been published on bisphosphonates-induced osteonecrosis of the jaw (BIONJ). 16 organizations have produced position papers, and tens of thousands of individuals have been afflicted by this serious drug-induced adverse side effect. The predictability of BIONJ occurring in humans has long been recognized, in the historical accounts of the phossy jaw epidemic between 1850 and 1906 and in the disease of osteopetrosis. BIONJ, as well as both of these pathologies, results from the over suppression of bone turnover (renewal), such that brittle and often necrotic bone develops in areas of the skeleton subject to the highest turnover in response to compressive forces and bending forces (e.g., alveolar bone in the jaws and the mid femur). The current challenge to clinicians is not to be ambivalent concerning the cause of BIONJ, as it is due to the bisphosphonate molecule itself, with all other medical conditions and drugs playing only contributing roles as co-morbidities. Accordingly, both the dose and the frequency of administration must be moderated. In addition, dental/oral and maxillofacial surgical teams must be able to competently manage and treat these individuals to control or resolve the disease.

Original languageEnglish (US)
Title of host publicationBisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach
PublisherSpringer-Verlag Italia s.r.l.
Pages1-11
Number of pages11
Volume9788847020832
ISBN (Print)9788847020832, 8847020824, 9788847020825
DOIs
StatePublished - May 1 2011

Fingerprint

Bisphosphonate-Associated Osteonecrosis of the Jaw
Jaw
Diphosphonates
Bone and Bones
Osteopetrosis
Femoral Fractures
Bone Remodeling
Poisons
Osteoclasts
Skeleton
Pharmaceutical Preparations
Femur
Publications
Tooth
Organizations
Pathology
Morbidity

Keywords

  • Bisphosphonate-induced osteonecrosis
  • Bisphosphonates
  • Exposed bone
  • Femur fractures
  • Fosamax
  • Osteoclasts
  • Phossy jaw
  • Strike anywhere matches
  • White phosphorus
  • Zometa

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Marx, R. (2011). Introduction. In Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach (Vol. 9788847020832, pp. 1-11). Springer-Verlag Italia s.r.l.. https://doi.org/10.1007/978-88-470-2083-2_1

Introduction. / Marx, Robert.

Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach. Vol. 9788847020832 Springer-Verlag Italia s.r.l., 2011. p. 1-11.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marx, R 2011, Introduction. in Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach. vol. 9788847020832, Springer-Verlag Italia s.r.l., pp. 1-11. https://doi.org/10.1007/978-88-470-2083-2_1
Marx R. Introduction. In Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach. Vol. 9788847020832. Springer-Verlag Italia s.r.l. 2011. p. 1-11 https://doi.org/10.1007/978-88-470-2083-2_1
Marx, Robert. / Introduction. Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach. Vol. 9788847020832 Springer-Verlag Italia s.r.l., 2011. pp. 1-11
@inbook{18a6568cec3c419a9ee78eebafcbfb4d,
title = "Introduction",
abstract = "Beginning with the first reports in 2001 and continuing to the present time, exposed bone in the jaws and, more recently, femoral fractures caused by the toxic effects of bisphosphonates on osteoclasts have become epidemic. In less than 10 years, more than 1,100 publications have been published on bisphosphonates-induced osteonecrosis of the jaw (BIONJ). 16 organizations have produced position papers, and tens of thousands of individuals have been afflicted by this serious drug-induced adverse side effect. The predictability of BIONJ occurring in humans has long been recognized, in the historical accounts of the phossy jaw epidemic between 1850 and 1906 and in the disease of osteopetrosis. BIONJ, as well as both of these pathologies, results from the over suppression of bone turnover (renewal), such that brittle and often necrotic bone develops in areas of the skeleton subject to the highest turnover in response to compressive forces and bending forces (e.g., alveolar bone in the jaws and the mid femur). The current challenge to clinicians is not to be ambivalent concerning the cause of BIONJ, as it is due to the bisphosphonate molecule itself, with all other medical conditions and drugs playing only contributing roles as co-morbidities. Accordingly, both the dose and the frequency of administration must be moderated. In addition, dental/oral and maxillofacial surgical teams must be able to competently manage and treat these individuals to control or resolve the disease.",
keywords = "Bisphosphonate-induced osteonecrosis, Bisphosphonates, Exposed bone, Femur fractures, Fosamax, Osteoclasts, Phossy jaw, Strike anywhere matches, White phosphorus, Zometa",
author = "Robert Marx",
year = "2011",
month = "5",
day = "1",
doi = "10.1007/978-88-470-2083-2_1",
language = "English (US)",
isbn = "9788847020832",
volume = "9788847020832",
pages = "1--11",
booktitle = "Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - CHAP

T1 - Introduction

AU - Marx, Robert

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Beginning with the first reports in 2001 and continuing to the present time, exposed bone in the jaws and, more recently, femoral fractures caused by the toxic effects of bisphosphonates on osteoclasts have become epidemic. In less than 10 years, more than 1,100 publications have been published on bisphosphonates-induced osteonecrosis of the jaw (BIONJ). 16 organizations have produced position papers, and tens of thousands of individuals have been afflicted by this serious drug-induced adverse side effect. The predictability of BIONJ occurring in humans has long been recognized, in the historical accounts of the phossy jaw epidemic between 1850 and 1906 and in the disease of osteopetrosis. BIONJ, as well as both of these pathologies, results from the over suppression of bone turnover (renewal), such that brittle and often necrotic bone develops in areas of the skeleton subject to the highest turnover in response to compressive forces and bending forces (e.g., alveolar bone in the jaws and the mid femur). The current challenge to clinicians is not to be ambivalent concerning the cause of BIONJ, as it is due to the bisphosphonate molecule itself, with all other medical conditions and drugs playing only contributing roles as co-morbidities. Accordingly, both the dose and the frequency of administration must be moderated. In addition, dental/oral and maxillofacial surgical teams must be able to competently manage and treat these individuals to control or resolve the disease.

AB - Beginning with the first reports in 2001 and continuing to the present time, exposed bone in the jaws and, more recently, femoral fractures caused by the toxic effects of bisphosphonates on osteoclasts have become epidemic. In less than 10 years, more than 1,100 publications have been published on bisphosphonates-induced osteonecrosis of the jaw (BIONJ). 16 organizations have produced position papers, and tens of thousands of individuals have been afflicted by this serious drug-induced adverse side effect. The predictability of BIONJ occurring in humans has long been recognized, in the historical accounts of the phossy jaw epidemic between 1850 and 1906 and in the disease of osteopetrosis. BIONJ, as well as both of these pathologies, results from the over suppression of bone turnover (renewal), such that brittle and often necrotic bone develops in areas of the skeleton subject to the highest turnover in response to compressive forces and bending forces (e.g., alveolar bone in the jaws and the mid femur). The current challenge to clinicians is not to be ambivalent concerning the cause of BIONJ, as it is due to the bisphosphonate molecule itself, with all other medical conditions and drugs playing only contributing roles as co-morbidities. Accordingly, both the dose and the frequency of administration must be moderated. In addition, dental/oral and maxillofacial surgical teams must be able to competently manage and treat these individuals to control or resolve the disease.

KW - Bisphosphonate-induced osteonecrosis

KW - Bisphosphonates

KW - Exposed bone

KW - Femur fractures

KW - Fosamax

KW - Osteoclasts

KW - Phossy jaw

KW - Strike anywhere matches

KW - White phosphorus

KW - Zometa

UR - http://www.scopus.com/inward/record.url?scp=84930856588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930856588&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-2083-2_1

DO - 10.1007/978-88-470-2083-2_1

M3 - Chapter

SN - 9788847020832

SN - 8847020824

SN - 9788847020825

VL - 9788847020832

SP - 1

EP - 11

BT - Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach

PB - Springer-Verlag Italia s.r.l.

ER -